细胞层面的衰老:年龄对创伤患者血小板动力学影响的探索性分析
本研究为前瞻性观察性研究的二次分析,纳入2010-2024年716例未使用抗血小板/抗凝药物且无孤立性颅脑损伤的创伤患者,中位年龄36岁(15-97岁)。多变量分析显示,在所有测量时间点,年龄增长与血小板计数降低、聚集反应降低及高凝凝血动态独立相关。在≥55岁患者中,入院时低血小板计数和聚集反应降低提示死亡率增加(均p<0.05)。结论提示年龄相关血小板改变可能预示更差结局,并可作为未来研究的可干预生物学靶点。
要点
- 在716例未用抗血小板/抗凝药且无孤立性颅脑损伤的创伤患者中,年龄增长与所有时间点血小板计数降低独立相关。
- 年龄增长同时与血小板聚集反应降低及高凝凝血动态独立相关,提示血小板功能与凝血状态随年龄出现分离性改变。
- 在≥55岁创伤患者中,入院时低血小板计数和低聚集反应与死亡率增加相关(均p<0.05)。
- 该研究为探索性二次分析,年龄相关血小板改变能否作为干预靶点尚需前瞻性研究验证。
适用人群与场景
- 适用人群:创伤患者,来自2010-2024年前瞻性观察性凝血与炎症研究,纳入时未使用抗凝药和/或抗血小板药,且排除孤立性创伤性脑损伤。
- 排除人群:使用抗凝药、抗血小板药和/或孤立性创伤性脑损伤的患者。
- 场景:急诊/ICU创伤患者,评估入院时及伤后 up to 7天的血小板计数与功能。
诊断标准与关键阈值
- 年龄分层界值:<55岁与≥55岁两组进行比较。
- 血小板功能评估:阻抗聚集法和黏弹性测试。
- 结局指标:血小板谱、血栓栓塞事件和死亡率。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- ≥55岁创伤患者入院时低血小板计数和聚集反应降低提示死亡率增加(均p<0.05),需警惕并加强监测。
研究设计与关键结果
- 研究类型:前瞻性观察性研究的二次分析,单中心?原文未提及中心数;样本量716例;中位年龄36岁(范围15-97岁)。
- 干预与对照:无干预,按年龄<55岁与≥55岁分层分析。
- 主要终点:多变量分析显示年龄增长与所有测量时间点血小板计数降低、聚集反应降低及高凝凝血动态独立相关。
- 关键次要终点:≥55岁患者入院时低血小板计数和低聚集反应与死亡率增加相关(均p<0.05)。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:前瞻性观察性研究的二次分析(探索性分析)。
- 证据等级或推荐强度:原文未提及。
- 局限:探索性二次分析;原文未提及中心数、样本量计算及混杂控制细节;年龄分层界值(55岁)为预设分析,需前瞻性验证。
对床旁实践的改变
- 对≥55岁创伤患者,入院时应关注血小板计数和聚集反应,低值可能提示死亡风险增加,但原文未给出具体干预措施。
- 年龄增长与高凝凝血动态相关,提示对老年创伤患者进行凝血监测时需综合评估血小板功能与黏弹性测试结果。
- 不适用于使用抗凝药/抗血小板药或孤立性颅脑损伤的创伤患者。
- 常见陷阱:不能将年龄相关血小板改变直接作为治疗指征,原文仅提示关联,需未来研究验证干预价值。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Increasing chronological age drives dynamic changes in platelet functionality, bringing unique biologic challenges to the injured older adult. While platelets play an indispensable role in injury response, the impact of age on platelet dynamics after injury remains elusive. We examine the associations of age and platelet dynamics for injured patients not on antiplatelet therapy, hypothesizing that aging is associated with decreases in platelet count and function in injured patients.
METHODS: We performed a secondary analysis of injured patients from a prospective observational study of coagulation and inflammation (2010-2024). Patients taking anticoagulants, antiplatelets, and/or with isolated traumatic brain injury were excluded. Univariable and multivariable associations of age and platelet count and function profiles (impedance aggregometry and viscoelastic testing) at presentation and up to seven days post-injury were analyzed. Platelet profiles, thromboembolic events, and mortality relationships were analyzed by stratifying age to <55 and ≥55 years.
RESULTS: 716 patients were examined. Median age was 36 years (range 15-97 years). On multivariable analyses platelet count and functional profiles demonstrated independent associations with increasing age at all time points measured - reduced platelet count, aggregation responses, and hypercoagulable clotting dynamics. In patients ≥55 years low platelet count and reduced aggregation responses on presentation were suggestive of increased mortality (all p<0.05).
CONCLUSION: Following injury, increasing chronological age is independently associated with altered platelet profiles - reduced platelet count and aggregation responses with concurrent hypercoagulable clotting dynamics. These age-related cellular changes may portend worse outcomes, including mortality, and should be considered for intervenable biologic targets in future study.
参考来源
- Beattie G, Joseph BA, Nunez-Garcia B, et al. Aging at the Cellular Level: An Exploratory Analysis of the Effect of Age on Platelet Dynamics in Injured Patients. Shock. 2026. PMID: 42678754. doi:10.1097/SHK.0000000000002934
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。